Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
1.3 trillion...gosh...sounds serious.
Interesting, can you PM that to me?
Selling in the 7s is dumb. I'm both in the trading club and the long club (mostly in the long club as I trade less than 1/3rd of my holdings) but my trade points are low 6s and high 8s right now. Everything else is just a waste of time.
You keep saying this, but there's never any substance to your argument, just like your other arguments. The last deal with Chicago Ventures worked out fine, even though you were saying the same thing last time.
Slow and steady wins the race.
Are you investing in this stock or trading it? If the latter, then you're doing it wrong. Investment means you're in it for the long haul, and with a high risk stock like this (all pennies are high risk), that means expect to hold it for many years before you make a profit, if you make one at all.
If you're just trading, then what are you doing complaining about the time period involved? You have to be constantly buying and selling this in very high volume to make any non-trivial amount, and the price is moving plenty for that kind of effort.
Personally, I'm doing both. I'm holding a reserve amount in anticipation of an eventual pop, and swing trading a smaller amount around the volatility. Because this stock is so predictable (due mainly to manipulation) it is easy to swing trade.
Interesting, when will this happen? I'll need to fill my account with extra cash to be ready to buy on the dip when it happens.
No need to reverse split. Once this acquisition is complete and paid for, (not this year, but possibly late 2020) MMs aren't going to keep this stock in the single digits unless they want to spend so much money that it's just not worth it.
Use Fidelity, you can trade just about anything with them, and it doesn't cost anything to have an idle account. I took advantage of their deal where you deposit 100k and get a crapload of free trades (way more than I'll even use.) They have a similar deal at 50k if you don't have that much. Even without that though, $4.95 for any trade isn't a bad deal at all.
Plus, they have a trade tool for free that let's you see level 2.
I personally am confident that RXMD will do well. Whenever it goes down, I've only rarely seen that not being due to manipulation. It's funny to watch because the riffraff indicates where the goal is for a bottom point, and people either don't sell enough or people see it for the bargain that it is and buy, thwarting that effort. That, and I like how at the low points, they sell below my bid.
Without even analyzing charts (I'm on mobile and don't want to right now) it looks like this is seeing hard resistance (or support, if you prefer) against downward manipulation by MMs at 6.5 cents. That's quite an improvement over the 5.7 cents about a month ago.
Who are you trying to kid anyways? I'm not even a full time investor (InfoSec is my day job) and I can see right through your attempts at misleading.
Yesterday I had two orders in that I bought for .002 and .003 lower than my bid. Obviously no manipulation there...
What part about 'the whole industry' don't you get? If you're fixating on margins, then the whole industry has to be used as a reference point. If it affects the whole industry, then guess what? It doesn't say anything good or bad about RXMD. Furthermore, that change in margin wasn't enough to put them underwater. You're really reaching here and you know it.
No, it very much wasn't. You were pointing out margins that declined to a number still above industry average, without mentioning anything about those other bits (which are bogus anyways.) Even that decline was at no fault of RXMD, it was due to a medicare change and it affected the entire industry.
You mean like that time when you were attacking RXMD based on its profit margins, even though they were above the industry average? If you were experienced in the business as you say, then how did you miss that?
When evaluating profit margin for investment, all that matters is the industry average. If your research was worth a shit, you'd know this.
Oh yes it can run away, and it will. I'm maintaining a minimum number of shares I'll hold at one time for that reason. This latest acquisition is huge, and then you have local news coverage of them with their opiate/CBD treatment.
Given RXMDs history of quickly paying off debts, as soon as that is complete, this stock will be irresistible at any price below .20.
I don't see anything particularly bad about January's numbers. IMO the current pps reflects profit taking, much as I've been doing, and no, I haven't yet refilled my sold shares (due to an error) but unlike most in my position, I'm not here to manipulate. RXMD is solid, and as the company's value increases, the stock price won't remain here. This is by far the stock in my portfolio that I have the most confidence will succeed.
Uhh...BS. I've been doing basically the opposite of what you've been saying and making money on this.
I'm still kicking myself that I forgot to put an order in at 6.4 like I intended to, I'm kind of low on shares now.
You're ignoring growth capex
So then, given the 80% gain over the last four weeks...
Because a 10% gain is basically red, right?
I'm a contributor at 17.5 :)
Well, I'm not complaining about an extra $6k in my pocket from this "basically red" day.
I'm thinking q3 before this will bounce. We need to see where those revenue numbers go QoQ, apples to apples. I think hitting the .10s between now and then is reasonable. Though if their q1 or q2 10q shows a big net income figure, then I'm wrong.
In the immortal words of straighttalk2004: "13% gain is basically red"
A lack of volume could speed its growth temporarily if many longs just aren't selling.
And Elvis has been hiding on Mars this whole time.
Is that because a 6.5% gain is red?
Oh hi Nostradamus! ...Oh wait...
Of course not. Look at the language used, earlier he was basically pleading with the longs to not buy during the dip. That's not a coincidence with what happened on L2 during that period.
Sitting on 500k shares here, my cost per share average just a hair below 4 cents. Already seeing good profit out of this, probably not going to sell for a few years. The bunk that comes out of the detractors here is just that: Bunk. I'm saying this in no uncertain terms: The company is in good shape.
Each time the detractors make claims (like profit margin, for example) it always turns out to be wrong when you take a closer look (notice how they stopped talking about it once I called them out?) As for this note, there's nothing toxic about it that I can see. RXMD has a history of quickly paying off their notes that are used for expansion. The only form of dilution that exists here is of the same type that exists in just about every other publicly traded company, and it's minimal at that.
After you consider growth capex, the company was very profitable this year, in spite of paper losses. Next year will probably look the same, but simultaneously, the company is about to see explosive growth with its recent acquisition.
Longs don't have anything to worry about.
I agree. This is textbook price manipulation.
At least somebody gets it: 10M order at 4 even. Whoever is selling right now is stupid.
That's what you said about their margins even though they were above the industry average.
That tends to happen when manipulators try to walk down the price when nobody wants to sell at the prices they're trying to get. The traders have already left, all that remains are the longs.
If you want more volume, then you should sell your shares at discount price.
Except that wasn't a flash crash, that was the result of an intense, coordinated (and expensive) walk down effort that didn't last more than a few hours. The most recent attempt couldn't even go that far.
Your facts amount to telling shareholders to sell TSLA because Elon Musk smoked weed. It's one of stupid, irrelevant, or misleading (you can see that he didn't inhale on the video.) RXMD is showing clear indications of growth. You're fixating on profit while the company is making big growth capex spending. If they weren't doing that, they would be showing a profit, but they wouldn't be growing. A company that doesn't grow isn't worth a shareholder's time.
Score? I haven't been keeping score, but I don't recall even one time that you've made an accurate prediction. You make so many that one would think you'd have accidentally guessed right by now.